NICE recommends SCS for spine pain management
The National Institute for Health and Clinical Excellence has issued a guidance which recommends the availability of Spinal Cord Stimulation (SCS) to all patients suffering from chronic neurologic pain for a minimum of 6 months after note benefiting from conventional treatment for pain management. Before implantation, the patients would go through a trial of the treatment. The guidance is a ray of hope for patients with Failed Back Surgery Syndrome (FBSS). In this therapy, electric pulses are sent to electrodes attached to a fully implanted neurostimulator battery. They interrupt the pain messages sent to the brain.
- FDA clearance to US Spine’s Preference 2 Complex Spine System™
- DePuy Spine launches minimally invasive spine system
- UCI to study novel method to treat pain, depression
- Bayer develops thinnest needle for MS
